IL319764A - הרכבים ושיטות לטיפול במחלת הנטינגטון - Google Patents
הרכבים ושיטות לטיפול במחלת הנטינגטוןInfo
- Publication number
- IL319764A IL319764A IL319764A IL31976425A IL319764A IL 319764 A IL319764 A IL 319764A IL 319764 A IL319764 A IL 319764A IL 31976425 A IL31976425 A IL 31976425A IL 319764 A IL319764 A IL 319764A
- Authority
- IL
- Israel
- Prior art keywords
- huntington
- disease
- compositions
- treatment
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/343—Spatial arrangement of the modifications having patterns, e.g. ==--==--==--
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/344—Position-specific modifications, e.g. on every purine, at the 3'-end
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3521—Methyl
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/353—Nature of the modification linked to the nucleic acid via an atom other than carbon
- C12N2310/3533—Halogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/52—Physical structure branched
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/35—Special therapeutic applications based on a specific dosage / administration regimen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263410857P | 2022-09-28 | 2022-09-28 | |
| PCT/US2023/075413 WO2024073595A2 (en) | 2022-09-28 | 2023-09-28 | Compositions and methods for treatment of huntington's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL319764A true IL319764A (he) | 2025-05-01 |
Family
ID=90479219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL319764A IL319764A (he) | 2022-09-28 | 2023-09-28 | הרכבים ושיטות לטיפול במחלת הנטינגטון |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP4594497A2 (he) |
| JP (1) | JP2025532883A (he) |
| KR (1) | KR20250075687A (he) |
| CN (1) | CN120569474A (he) |
| AU (1) | AU2023354001A1 (he) |
| CA (1) | CA3268993A1 (he) |
| IL (1) | IL319764A (he) |
| MX (1) | MX2025003636A (he) |
| WO (1) | WO2024073595A2 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2046993A4 (en) * | 2006-07-07 | 2010-11-17 | Univ Massachusetts | RNA SILENCING COMPOSITIONS, AND METHODS OF TREATING HUNTINGTON CHOREA |
| SMT202000454T1 (it) * | 2015-04-03 | 2020-11-10 | Univ Massachusetts | Cmposti oligonucleotidici per bersagliare l'mrn della huntingtina |
| WO2022204430A1 (en) * | 2021-03-24 | 2022-09-29 | Atalanta Therapeutics, Inc. | Double-stranded sirna having patterned chemical modifications |
| JP2024521897A (ja) * | 2021-06-02 | 2024-06-04 | アタランタ セラピューティクス,インコーポレーテッド | 治療用オリゴヌクレオチドを中枢神経系に送達するための組成物及び方法 |
-
2023
- 2023-09-28 IL IL319764A patent/IL319764A/he unknown
- 2023-09-28 WO PCT/US2023/075413 patent/WO2024073595A2/en not_active Ceased
- 2023-09-28 EP EP23873936.1A patent/EP4594497A2/en active Pending
- 2023-09-28 CN CN202380076889.9A patent/CN120569474A/zh active Pending
- 2023-09-28 JP JP2025518189A patent/JP2025532883A/ja active Pending
- 2023-09-28 KR KR1020257013817A patent/KR20250075687A/ko active Pending
- 2023-09-28 AU AU2023354001A patent/AU2023354001A1/en active Pending
- 2023-09-28 CA CA3268993A patent/CA3268993A1/en active Pending
-
2025
- 2025-03-27 MX MX2025003636A patent/MX2025003636A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025532883A (ja) | 2025-10-03 |
| MX2025003636A (es) | 2025-06-02 |
| EP4594497A2 (en) | 2025-08-06 |
| AU2023354001A1 (en) | 2025-04-17 |
| WO2024073595A2 (en) | 2024-04-04 |
| WO2024073595A3 (en) | 2024-05-16 |
| CA3268993A1 (en) | 2024-04-04 |
| CN120569474A (zh) | 2025-08-29 |
| KR20250075687A (ko) | 2025-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304137A (he) | שיטות ותכשירים לטיפול באטקסיית פרידרייך | |
| PT3861985T (pt) | Composições e métodos para tratar doenças oculares | |
| ZA202210984B (en) | Methods of treating coronavirus disease 2019 | |
| EP4370131A4 (en) | METHODS FOR TREATING ALZHEIMER'S DISEASE | |
| EP4028027A4 (en) | COMPOSITIONS AND METHODS FOR TREATING FRIEDREICH AAXIA | |
| IL319764A (he) | הרכבים ושיטות לטיפול במחלת הנטינגטון | |
| HK40130541A (en) | Compositions and methods for treatment of huntington's disease | |
| CA3272237A1 (en) | Compositions and methods for treatment of friedreich's ataxia | |
| GB202302434D0 (en) | Compositions and method for the treatment of onychomycosis | |
| HK40104489A (en) | Methods and compositions for treatment of friedreich's ataxia | |
| IL315725A (he) | שיטות ותכשירים לטיפול במחלת פרקינסון | |
| HK40111954A (en) | Genome editing compositions and methods for treatment of wilson's disease | |
| HK40111005A (en) | Genome editing compositions and methods for treatment of wilson's disease | |
| IL316340A (he) | שיטות ותכשירים לטיפול במחלת עין בלוטת התריס | |
| IL321723A (he) | הרכבים ושיטות לטיפול במחלת פרקינסון | |
| EP4132470A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASES | |
| MX2025006287A (es) | Trehalosa para el tratamiento de la enfermedad de huntington | |
| CA3280976A1 (en) | Methods and compositions for treating huntington's disease and its symptoms | |
| HK40088916A (en) | Use of bromodomain inhibitors for treatment of huntington's disease | |
| AU2022901418A0 (en) | Compositions and method for treatment of kidney disease 2 | |
| HK40123970A (en) | Methods and compositions for treatment of thyroid eye disease | |
| HK40119763A (en) | Compositions and methods for treatment of thyroid eye disease | |
| HK40119764A (en) | Compositions and methods for treatment of thyroid eye disease | |
| GB202007708D0 (en) | Materials and methods for treatment of dupuytren's disease | |
| IL314586A (he) | הרכבים ושיטות לטיפול משופר במחלת פומפה |